Building homogeneous time-resolved fluorescence resonance energy transfer assays for characterization of bivalent inhibitors of an inhibitor of apoptosis protein target
Charu Chaudhry(Bristol-Myers Squibb (Germany)), Randy Talbott(Bristol-Myers Squibb (United States)), Brigitte Devaux(Bristol-Myers Squibb (United States)), Chunhong Yan(Zhejiang University), Shana Posy(Bristol-Myers Squibb (Germany)), Henry Shen(Bristol-Myers Squibb (United States)), Yong Zhang(Princeton University), Litao Zhang(Tianjin University of Traditional Chinese Medicine), Jonathan H. Davis(Bristol-Myers Squibb (Germany)), Ming Lei(Bristol-Myers Squibb (United States)), R. M. Borzilleri(Bristol-Myers Squibb (Sweden)), William J. Metzler(Bristol-Myers Squibb (United States)), Yuval Blat(Bristol-Myers Squibb (Germany))
Cited by 3
Related Papers
Decarboxylative alkylation for site-selective bioconjugation of native proteins via oxidation potentials
|Nature Chemistry|2017|378
Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis
|Annals of Allergy Asthma & Immunology|2003|214
Ezh2 regulates differentiation and function of natural killer cells through histone methyltransferase activity
|Proceedings of the National Academy of Sciences|2015|168
Inhibition of influenza virus replication via small molecules that induce the formation of higher-order nucleoprotein oligomers
|Proceedings of the National Academy of Sciences|2011|139
Involvement of DPP‐IV catalytic residues in enzyme–saxagliptin complex formation
|Protein Science|2008|128